Demodex blepharitis is a common condition of eyelid inflammation. Lotilaner is the first FDA-approved, targeted treatment, offering effective mite eradication with minimal side effects.
Nusaiba Hamsho
Advertisement
Articles by Nusaiba Hamsho
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Evolving Strategies for RSV Prevention in Infants
2
UB-VV111: First In Vivo CAR T Candidate Moves Forward With FDA Fast Track Designation
3
FDA Approves First Oral Targeted BTKi Treatment for Patients with Chronic Hives
4
Novel Gene Therapy Significantly Slows Progression of Huntington Disease
5
